FIGS (FIGS) AI Stock Analysis

• Market Cap: $1.06B
• Dividend Yield: N/A
• Average Volume (3M): 2.12M
• Price to Earnings (P/E): 1083.3
• Beta (1Y): 0.95
• Revenue Growth: 3.02%
• EPS Growth: -94.52%
• Country: US
• Employees: 303
• Sector: Consumer Cyclical
• Sector Strength: 68
• Industry: Apparel - Manufacturers
• EPS (TTM): 0.00
• Shares Outstanding: 154,267,490
• 10 Day Avg. Volume: 1,760,641
• 30 Day Avg. Volume: 2,122,453
• PEG Ratio: -14.60
• Price to Book (P/B): 2.51
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 15.75
• Enterprise Value/Market Cap: 0.87
• Enterprise Value/Revenue: 0.41
• Enterprise Value/Gross Profit: 2.43
• Enterprise Value/Ebitda: 17.11
• 1Y Price Target: $4.90
• Price Target Upside: -24.62% Downside
• Rating Consensus: Hold
• Number of Analyst Covering: 7

• Rating: 75 Outperform
• Price Target: $7.00 ▲(7.69%Upside)

FIGS scores well due to a strong financial foundation and positive technical momentum. However, overvaluation concerns and macroeconomic challenges from tariffs weigh on the score. Earnings call insights show growth potential but highlight significant risks that need addressing.

Positive Factors

Gross Margin

Raising the price objective to $4.80 to reflect some gross margin upside opportunity as tariffs normalize.

International Growth

International revenue is a key growth driver, with expansion plans into Japan and South Korea.

Sales Performance

Sales trends have remained positive with an increase in both new and reactivated customers.

Negative Factors

Margin Pressure

Declining sales and margin pressure will prohibit multiple expansion and retain the Underperform rating.

Profitability

Margin pressure is expected to continue as tariffs and promotional activities affect profitability.

Tariff Impact

The company faces a headwind of 100-150 basis points on margins due to tariffs.

FIGS Business Overview & Revenue Model

Company Description

FIGS, Inc. is a healthcare apparel and lifestyle brand that specializes in designing and selling high-quality medical scrubs and related products. The company is based in Santa Monica, California, and primarily serves healthcare professionals with innovative, comfortable, and stylish apparel. FIGS aims to revolutionize the healthcare apparel industry by combining fashion, function, and affordability, thereby enhancing the work-life experience of healthcare professionals.

How the Company Makes Money

FIGS makes money primarily through the direct-to-consumer sales of its medical apparel products, such as scrubs, lab coats, underscrubs, outerwear, activewear, loungewear, and accessories. The company operates an e-commerce platform, which is its main channel for reaching customers, allowing it to bypass traditional retail markups and offer competitive pricing. FIGS focuses on building brand loyalty through high-quality products and community engagement with healthcare professionals. Additionally, the company benefits from customer word-of-mouth and targeted marketing strategies, which contribute to its growing customer base and revenue. While FIGS does not currently report significant partnerships as a major revenue factor, its innovative product offerings and strong consumer base are key contributors to its financial success.

FIGS Financial Statement Overview

Summary

FIGS maintains a robust balance sheet with low leverage and high equity ratios, providing a stable financial foundation. The strong cash flow management and effective cost management are offset by pressures in profitability margins and negative free cash flow growth.

Income Statement

FIGS shows a strong gross profit margin of 67.1% TTM, reflecting efficient cost management. However, the company faces challenges in net profit margin, which is only 0.2% TTM, indicating slim overall profitability despite revenue growth of 1% TTM. EBIT and EBITDA margins remain low at 0.3% and 1.1% respectively, suggesting pressure in operational efficiency.

Balance Sheet

FIGS maintains a robust balance sheet with a debt-to-equity ratio of 0.13, indicating low leverage. The equity ratio is strong at 73%, showcasing financial stability. Return on equity stands at 0.3% TTM, which is modest but shows potential for improvement.

Cash Flow

FIGS demonstrates positive cash flow management with an operating cash flow to net income ratio of 66.6 TTM, reflecting effective cash generation relative to earnings. Free cash flow to net income is high at 51.5 TTM, although free cash flow growth is negative at -5% TTM, suggesting challenges in sustaining cash flow momentum.

Breakdown	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	555.56M	545.65M	505.83M	419.59M	263.11M
Gross Profit	375.62M	376.96M	354.46M	301.22M	190.22M
EBITDA	8.96M	36.99M	39.59M	11.52M	58.89M
Net Income	2.72M	22.64M	21.19M	-9.56M	49.76M
Balance Sheet
Total Assets	509.79M	473.21M	395.06M	311.75M	133.85M
Cash, Cash Equivalents and Short-Term Investments	245.11M	246.69M	159.78M	195.37M	58.13M
Total Debt	53.03M	47.11M	19.16M	0.00	0.00
Total Liabilities	132.66M	96.36M	87.33M	66.18M	36.18M
Stockholders Equity	377.13M	376.85M	307.74M	245.57M	97.68M
Cash Flow
Free Cash Flow	64.14M	84.57M	-40.68M	63.73M	19.49M
Operating Cash Flow	81.16M	100.92M	-35.33M	66.44M	21.75M
Investing Cash Flow	-94.92M	-117.19M	-5.85M	-2.71M	-2.26M
Financing Cash Flow	-44.77M	670.00K	3.52M	75.57M	294.00K

FIGS Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 6.50
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For FIGS, the sentiment is Positive. The current price of 6.5 is above the 20-day moving average (MA) of 6.19, above the 50-day MA of 5.54, and above the 200-day MA of 5.30, indicating a bullish trend. The MACD of 0.27 indicates Positive momentum. The RSI at 54.66 is Neutral, neither overbought nor oversold. The STOCH value of 54.99 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for FIGS.

FIGS Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
FIGS	75 Outperform	$1.06B	1,083.33	0.31%	―	3.02%	-94.52%
GIII	71 Outperform	$1.02B	5.46	12.21%	―	1.72%	13.75%
Sector *	62 Neutral	AU$2.98B	28.70	4.69%	4.87%	2.32%	-33.09%
OXM	62 Neutral	$552.16M	7.18	13.63%	7.36%	-2.47%	99.50%
UA	62 Neutral	$2.76B	―	-9.95%	―	-7.47%	-131.70%
AIN	58 Neutral	$1.60B	27.04	6.71%	1.51%	-5.16%	-42.62%
UFI	48 Neutral	$83.36M	―	-15.73%	―	2.51%	32.95%

FIGS Corporate Events

FIGS Holds Annual Stockholders Meeting via Webcast

On June 4, 2025, FIGS, Inc. held its annual meeting of stockholders via live webcast, where a quorum was established with over 95% of the combined voting power of its Class A and Class B common stock. During the meeting, stockholders elected three Class I directors to serve until 2028, ratified the appointment of Ernst & Young LLP as the independent registered public accounting firm for 2025, and approved the compensation of the company’s named executive officers on a non-binding basis.

The most recent analyst rating on (FIGS) stock is a Buy with a $7.25 price target. To see the full list of analyst forecasts on FIGS stock, see the FIGS Stock Forecast page.

FIGS Reports Q1 2025 Revenue Growth Amid Tariff Challenges

On May 8, 2025, FIGS, Inc. announced its first quarter 2025 financial results, reporting a net revenue increase of 4.7% year over year, driven by higher orders from existing customers and increased average order value. Despite a decrease in gross margin and adjusted EBITDA, the company showed signs of growth in the U.S. and international markets, with a notable 16.4% rise in international net revenues. FIGS updated its full-year 2025 outlook to account for U.S. tariff impacts, highlighting the company’s strategic focus on maintaining its market leadership amidst economic uncertainties.